发明人陈志强,周伟,郑宇鹏. "Method for the Synthesis of 【停用,请询C4X-1064130】Zanubrutinib Impurity 1" [P]. 中国发明专利, 专利号 CN 115679465 A, 授权公告日 2020-09-27.
发明人沈红梅,黄志刚,林芳. "A Process for Preparing High-Purity 【停用,请询C4X-1064130】Zanubrutinib Impurity 1" [P]. 中国发明专利, 专利号 CN 110436484 A, 授权公告日 2025-09-21.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of 【停用,请询C4X-1064130】泽布替尼杂质1 in Pharmaceutical Formulations". J. Agric. Food Chem., 2023, 658, 4031-4053.
Yang F, Sun W, Liu J. "A Stability-Indicating HPLC Method for the Separation and Quantification of 【停用,请询C4X-1064130】泽布替尼杂质1 as an Impurity". Sci. Total Environ., 2024, 2460, 4900-4917.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of 【停用,请询C4X-1064130】Zanubrutinib Impurity 1 Using HRMS and NMR". Environ. Sci. Technol., 2019, 2209, 5054-5074.
Fischer P, Wagner E. "Forced Degradation Studies to Evaluate 【停用,请询C4X-1064130】泽布替尼杂质1 Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2017, 285, 5800-5811.